Trademark: 86790734
Status Date
Tuesday, October 16, 2018
Registration Number
5583190
Registration Date
Tuesday, October 16, 2018
Filing Date
Friday, October 16, 2015
Published for Opposition
Tuesday, July 31, 2018
5 amino acids for medical purposes; biological preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; blood for medical purposes; blood plasma; capsules sold empty for pharmaceuticals; chemical reagents for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; detergents for medical purposes; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; drugs for medical purpose, namely, pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases; pharmaceutical preparations for treatment of immune system related diseases, cancer and infectious diseases; reagent paper for medical purposes; medicated serums for treatment of immune system related diseases, cancer and infectious diseases; sugar for medical purposes; vaccines; Anti-cancer preparations; Biological preparations for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and antiangiogenic therapy; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for using in oncology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers
Mar 27, 2024
Teas Change Of Correspondence Received
Mar 27, 2024
Teas Withdrawal As Domestic Representative Received
Mar 27, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 27, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 27, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 27, 2024
Teas Change Of Owner Address Received
Oct 16, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 16, 2018
Registered-Principal Register
Jul 31, 2018
Official Gazette Publication Confirmation E-Mailed
Jul 31, 2018
Published For Opposition
Jul 11, 2018
Notification Of Notice Of Publication E-Mailed
Jun 22, 2018
1(B) Basis Deleted; New Basis Requested
Jun 22, 2018
Notice Of Allowance Cancelled
Jun 21, 2018
Attorney Review/Decision On Amendment Required
Jun 21, 2018
Petition To Director - Change Basis - Granted
Jun 21, 2018
Attorney Review/Decision On Amendment Required
Jun 21, 2018
Petition To Director - Change Basis - Granted
Jun 12, 2018
Teas Response To Petition Inquiry Letter
Jun 4, 2018
Petition Inquiry Letter Issued
Jun 1, 2018
Assigned To Petition Staff
May 1, 2018
Paper Received
Apr 27, 2018
Teas Petition To Amend Basis Received
Mar 28, 2018
Notice Of Approval Of Extension Request E-Mailed
Mar 26, 2018
Sou Extension 3 Granted
Mar 26, 2018
Sou Extension 3 Filed
Mar 26, 2018
Sou Teas Extension Received
Feb 20, 2018
Assigned To Examiner
Oct 6, 2017
Notice Of Approval Of Extension Request E-Mailed
Oct 4, 2017
Sou Extension 2 Granted
Oct 4, 2017
Sou Extension 2 Filed
Oct 4, 2017
Sou Teas Extension Received
Mar 10, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 8, 2017
Sou Extension 1 Granted
Mar 8, 2017
Sou Extension 1 Filed
Mar 8, 2017
Sou Teas Extension Received
Oct 25, 2016
Noa E-Mailed - Sou Required From Applicant
Aug 30, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 30, 2016
Published For Opposition
Aug 10, 2016
Notification Of Notice Of Publication E-Mailed
Jul 26, 2016
Law Office Publication Review Completed
Jul 21, 2016
Approved For Pub - Principal Register
Jul 19, 2016
Teas/Email Correspondence Entered
Jul 19, 2016
Correspondence Received In Law Office
Jul 14, 2016
Assigned To Lie
Jul 8, 2016
Teas Response To Office Action Received
Feb 8, 2016
Notification Of Non-Final Action E-Mailed
Feb 8, 2016
Non-Final Action E-Mailed
Feb 8, 2016
Non-Final Action Written
Feb 8, 2016
Assigned To Examiner
Oct 21, 2015
New Application Office Supplied Data Entered
Oct 20, 2015
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
